Ali Behbahani sold $781K of CRISPR Therapeutics AG (CRSP)

Executed Sep 17, disclosed Sep 21, 4 days later.

Value, as filed

$781K

13,679 sh × $57.09

Executed

Sep 17

the trade date, as filed

Disclosed

Sep 21

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AB Ali Behbahani Director profile →

Ali Behbahani (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ADAP. Across 1 priced purchase filing, the average 21-session return was +6.2% from execution and -5.7% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of SGP (937,500 sh × $16.00, as filed), executed Feb 9.

The name

CRSP

CRISPR Therapeutics AG CRSP · Healthcare · 34 filings in 24 months ticker →

Healthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→